Evidence map›Paper›PMID 28373537›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Structure-metabolism relationships in

Susan Lepri, Martina Ceccarelli, Nicolò Milani, Sara Tortorella, Andrea Cucco, Aurora Valeri, Laura Goracci, Andreas Brink, Gabriele Cruciani

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The pyridazine heterocycle in molecular recognition and drug discovery.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2023
    Review
  5. Review
  6. Ready access to 7,8-dihydroindolo[2,3-Beilstein journal of organic chemistry · 2022
    Article
  7. Toxicology reports · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Fast Methods for Prediction of Aldehyde Oxidase-Mediated Site-of-Metabolism.Computational and structural biotechnology journal · 2019
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Susan LepriDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0003-1024-7368
Martina CeccarelliDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.
Nicolò MilaniDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.
Sara TortorellaDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.
Andrea CuccoDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.
Aurora ValeriDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0003-4027-7613
Laura GoracciDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.
Andreas BrinkRoche Pharma Research and Early Development, Drug Disposition and Safety, Roche Innovation Center Basel, F. Hoffmann-La Roche, Ltd., 4070 Basel, Switzerland.
Gabriele CrucianiDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy; gabriele.cruciani@unipg.it.
University of Perugia · ITRoche (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aldehyde oxidase (AOX) is a metabolic enzyme catalyzing the oxidation of aldehyde and aza-aromatic compounds and the hydrolysis of amides, moieties frequently shared by the majority of drugs. Despite its key role in human metabolism, to date only fragmentary information about the chemical features responsible for AOX susceptibility are reported and only "very local" structure-metabolism relationships based on a small number of similar compounds have been developed. This study reports a more comprehensive coverage of the chemical space of structures with a high risk of AOX phase I metabolism in humans. More than 270 compounds were studied to identify the site of metabolism and the metabolite(s). Both electronic [supported by density functional theory (DFT) calculations] and exposure effects were considered when rationalizing the structure-metabolism relationship.

Indexed as

Databases, PharmaceuticalAldehyde OxidaseAmidesAza CompoundsBiocatalysisHumansHydrocarbons, AromaticOxidation-ReductionProtein ConformationSubstrate SpecificityAldehyde OxidaseAmidesAOX1 protein, humanAza CompoundsHydrocarbons, Aromaticaldehyde oxidaseamide hydrolysissite of metabolismstructure–metabolism relationshipvariously decorated heterocycles

Identifiers

PMID28373537
PMCPMC5402434
OpenAlexW2604139305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.